InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,620.85
(
0.42%
)
US TECH 100
19,332.00
(
0.63%
)
Dow Jones
40,890.49
(
0.14%
)
Brent Oil
75.58
(
-0.15%
)
Bitcoin
61,180.00
(
0.00%
)
Post# of 21541
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

InTheTrenches

Send PM Follow Ignore
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

InTheTrenches

Re: InTheTrenches post# 7775

Sunday, 01/06/2019 11:34:01 PM

Sunday, January 06, 2019 11:34:01 PM

Post# of 21541
As a follow-up post RE: the safety of Bryostatin, I was reading this article (posted by runncoach, I think):

https://www.scribd.com/document/386853846/Bryostatin-1-alleviates-experimental-multiple-sclerosis

The authors of this peer-reviewed PNAS article unequivocally state:

"The established clinical safety profile of bryostatin-1 in humans could expedite its development as a therapeutic agent in MS"


It's quite clear that the clinical safety of Bryostatin is established to top researchers in the field.

-------------

[ "PNAS is one of the world's most-cited and comprehensive multidisciplinary scientific journals ... papers undergo rigorous peer review and approval by an NAS member before publication." ]

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM

Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM

Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Start posting your company's news
Only $200 per official company press release!